Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies ; volume:33 ; number:5 ; day:16 ; month:9 ; year:2019 ; pages:571-579 ; date:10.2019
BioDrugs ; 33, Heft 5 (16.9.2019), 571-579, 10.2019
- Creator
-
Wang, Ellen Q.
Bukowski, Jack F.
Yunis, Carla
Shear, Charles L.
Ridker, Paul M.
Schwartz, Pamela F.
Baltrukonis, Daniel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-019-00375-0
- URN
-
urn:nbn:de:101:1-2020013012334473754585
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Ellen Q.
- Bukowski, Jack F.
- Yunis, Carla
- Shear, Charles L.
- Ridker, Paul M.
- Schwartz, Pamela F.
- Baltrukonis, Daniel
- SpringerLink (Online service)
Other Objects (12)
Establishment of anti-mesothelioma monoclonal antibodies
Anti-Bodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Anti-CCP antibodies and bone
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Establishment of anti-mesothelioma monoclonal antibodies
Anti-Bodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Anti-CCP antibodies and bone
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Establishment of anti-mesothelioma monoclonal antibodies
Anti-Bodies
Monoclonal antibodies
Anti-allergen monoclonal antibodies for the treatment of allergies
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
Anti-CCP antibodies and bone